NCT06020651 2023-08-31
VICKI
Institut Mutualiste Montsouris
Phase NA Unknown
Clinical Trials
14 trialsNCT03381326 2023-06-02
IRSTB030
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Unknown
NCT05285579 2023-04-19
ANGIOCOR
Assistance Publique - Hôpitaux de Paris
Unknown
NCT05426317 2022-06-22
Onco-PDL1s/B2M
University Hospital, Clermont-Ferrand
Phase NA Unknown
NCT04774133 2021-03-01
The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.
Regina Elena Cancer Institute
Phase NA Unknown
NCT04746300 2021-02-09
PROMPT
Radboud University Medical Center
Unknown
NCT00503893 2020-01-27
Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
M.D. Anderson Cancer Center
Unknown
NCT02963155 2020-01-10
NKPROSTATE
Institut Paoli-Calmettes
Phase NA Unknown
NCT03185039 2020-01-10
Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents
Institut Paoli-Calmettes
Phase NA Unknown
NCT03846128 2019-07-23
BIOSUNTOX
University Hospital, Rouen
Unknown
NCT03667885 2019-03-19
NISar
Odense University Hospital
Unknown
NCT02940977 2018-07-10
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Unknown
NCT02723526 2016-03-31
Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer
Fudan University
Unknown
NCT00957606 2011-04-13
Osteoporosis
Odense University Hospital
Phase 3 Unknown